09:04 / Tradegate
WKN: A2GS5D / Name: Dermapharm Holding / Stock / Holding Companies / ?
Dermapharm Holding SE Stock
We can see a decrease in the price for Dermapharm Holding SE. Compared to yesterday it has lost -€1.040 (-1.730%).
Currently there is a rather positive sentiment for Dermapharm Holding SE with 5 Buy predictions and 1 Sell predictions.
With a target price of €63.00 there is a slightly positive potential of 6.925% for Dermapharm Holding SE compared to the current price of €58.92.
Currently there is a rather positive sentiment for Dermapharm Holding SE with 5 Buy predictions and 1 Sell predictions.
With a target price of €63.00 there is a slightly positive potential of 6.925% for Dermapharm Holding SE compared to the current price of €58.92.
Pros and Cons of Dermapharm Holding SE in the next few years
Pros
?
Brand
?
Shareholder structure
?
Market Position
Cons
?
Conscious of the environment
?
Growth compared to competition
?
Worthwhile Investment for the next years
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dermapharm Holding SE vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dermapharm Holding SE | -1.730% | -1.544% | -4.355% | 50.200% | 4.387% | - | - |
| Emerita Resources | 1.670% | 0.549% | 40.769% | 297.826% | 27.972% | - | - |
Other discussions about Dermapharm Holding SE Stock
New thread ForumNews
DGAP-News: Dermapharm Holding SE continues on its growth course in third quarter of 2020
DGAP-News: Dermapharm Holding SE continues on its growth course in third quarter of 2020
DGAP-News: Dermapharm Holding SE - subsidiary axicorp GmbH breaks ground for a new building near Frankfurt/Main
DGAP-News: Dermapharm Holding SE - subsidiary axicorp GmbH breaks ground for a new building near Frankfurt/Main
DGAP-News: Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine
DGAP-News: Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine